Cell therapy for human ischemic heart diseases: Critical review and summary of the clinical experiences

Journal of Molecular and Cellular Cardiology

Volumn 75, Issue , 2014, Pages 12-24

  Pavo, Noemi ^a   Charwat, Silvia ^a   Nyolczas, Noemi ^a   Jakab, András ^b   Murlasits, Zsolt ^c   Bergler Klein, Jutta ^a   Nikfardjam, Mariam ^a   Benedek, Imre ^d   Benedek, Teodora ^d   Pavo, Imre J ^a   Gersh, Bernard J ^e   Huber, Kurt ^f   Maurer, Gerald ^a   Gyöngyösi, Mariann ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF MEMPHIS   (United States)

^d UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^f WILHELMINEN HOSPITAL   (Austria)

Author keywords

Cardiac regeneration; Cardio myogenic stem and progenitor cells; Human clinical trial; Intracoronary delivery; Intramyocardial injection; Myocardial infarction; Review

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ACUTE HEART INFARCTION; ADIPOSE DERIVED STEM CELL; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MARROW ORIGIN MONONUCLEAR CELL; CARDIAC REGENERATION; CARDIAC SHOCK WAVE THERAPY; CARDIAC STEM CELL; CARDIOSPHERE DERIVED CELL; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CELL RELATED GENE THERAPY; CELL THERAPY; CELLS BY BODY ANATOMY; CLINICAL EFFECTIVENESS; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); CORONARY SINUS CELL DELIVERY; EMBRYONIC STEM CELL; ENDOMETRIAL REGENERATIVE CELL; EXTRACORPOREAL LITHOTRIPSY; FEASIBILITY STUDY; FOLLOW UP; GENE THERAPY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTRACORONARY CELL DELIVERY; ISCHEMIC HEART DISEASE; MOLECULAR DYNAMICS; MYOBLAST; NONHUMAN; OUTCOME ASSESSMENT; PARACRINE SIGNALING; PATIENT SAFETY; PERCUTANEOUS INTRAMYOCARDIAL CELL DELIVERY; PHENOTYPICALLY MODIFIED STEM CELL; PLURIPOTENT STEM CELL; PROCEDURES CONCERNING CELLS; REVIEW; SATELLITE CELL; STEM CELL; STEM CELL LIKE CELL; STEM CELL TRANSPLANTATION; TIME TO TREATMENT; TISSUE ENGINEERING; TISSUE REGENERATION; WORK EXPERIENCE; HEART; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; REGENERATION; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; HEART; HUMANS; MYOCARDIAL ISCHEMIA; REGENERATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84916913763     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.06.016     Document Type: Review

References (232)

1. Dargie H. Heart failure post-myocardial infarction: a review of the issues. Heart 2005, 91(Suppl. II):ii3-ii6.
2. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
3. Chiu R.C., Zibaitis A., Kao R.L. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995, 60:12-18.
4. Quaini F., Urbanek K., Beltrami A.P., Finato N., Beltrami C.A., Nadal-Ginard B., et al. Chimerism of the transplanted heart. N Engl J Med 2002, 346:5-15.
5. Laflamme M.A., Myerson D., Saffitz J.E., Murry C.E. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 2002, 90:634-640.
6. Frangogiannis N.G., Mendoza L.H., Ren G., Akrivakis S., Jackson P.L., Michael L.H., et al. MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. Am J Physiol 2003, 285:H483-H492.
7. Kajstura J., Leri A., Finato N., Di Loreto C., Beltrami C.A., Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A 1998, 95:8801-8805.
8. Beltrami A.P., Urbanek K., Kajstura J., Yan S.M., Finato N., Bussani R., et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001, 344:1750-1757.
9. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabé-Heider F., Walsh S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
10. Pouzet B., Vilquin J.T., Hagège A.A., Scorsin M., Messas E., Fiszman M., et al. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?. Circulation 2000, 102(19 Suppl 3):III210-III215.
11. Smits P.C., van Geuns R.J., Poldermans D., Bountioukos M., Onderwater E.E., Lee C.H., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 2003, 42:2063-2069.
12. Dib N., Diethrich E.B., Campbell A., Goodwin N., Robinson B., Gilbert J., et al. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction. J Endovasc Ther 2002, 9:313-319.
13. Menasché P. Stem cell therapy for heart failure: are arrhythmias a real safety concern?. Circulation 2009, 119:2735-2740.
14. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001, 98:10344-10349.
15. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705.
16. Orlic D., Hill J., Arai A. Stem cells for myocardial regeneration. Circ Res 2002, 91:1092-1102.
17. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436.
18. Luth E.S., Jun S.J., Wessen M.K., Liadaki K., Gussoni E., Kunkel L.M. Bone marrow side population cells are enriched for progenitors capable of myogenic differentiation. J Cell Sci 2008, 121:1426-1434.
19. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003, 108:2511-2516.
20. Badorff C., Brandes R.P., Popp R., Rupp S., Urbich C., Aicher A., et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003, 107:1024-1032.
21. Strauer B.E., Brehm M., Zeus T., Köstering M., Hernandez A., Sorg R.V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918.
22. Assmus B., Schächinger V., Teupe C., Britten M., Lehmann R., Döbert N., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002, 106:3009-3017.
23. Gu X., Xie Y., Gu J., Sun L., He S., Xu R., et al. Repeated intracoronary infusion of peripheral blood stem cells with G-CSF in patients with refractory ischemic heart failure - A Pilot Study. Circ J 2011, 75:955-963.
24. Li Z.Q., Zhang M., Jing Y.Z., Zhang W.W., Liu Y., Cui L.J., et al. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). Int J Cardiol 2007, 115:52-56.
25. Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004, 363:751-756.
26. Kang H.J., Lee H.Y., Na S.H., Chang S.A., Park K.W., Kim H.K., et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006, 144:I145-I151.
27. Schächinger V., Assmus B., Britten M.B., Honold J., Lehmann R., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 2004, 44:1690-1699.
28. Bartunek J., Vanderheyden M., Vandekerckhove B., Mansour S., De Bruyne B., De Bondt P., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005, 112:I178-I183.
29. Assmus B., Honold J., Schächinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355:1222-1232.
30. Assmus B., Fischer-Rasokat U., Honold J., Seeger F.H., Fichtlscherer S., Tonn T., et al. TOPCARE-CHD Registry. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res 2007, 100:1234-1241.
31. Tendera M., Wojakowski W., Ruzyllo W., Chojnowska L., Kepka C., Tracz W., et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 2009, 30:1313-1321. REGENT Investigators.
32. Quyyumi A.A., Waller E.K., Murrow J., Esteves F., Galt J., Oshinski J., et al. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J 2011, 161:98-105.
33. Povsic T.J., Junge C., Nada A., Schatz R.A., Harrington R.A., Davidson C.J., et al. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. Am Heart J 2013, 165:854-861.
34. Rehman J. Bone marrow tinctures for cardiovascular disease: lost in translation. Circulation 2013, 127:1935-1937.
35. Makino S., Fukuda K., Miyoshi S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999, 103:697-705.
36. Zhang S., Jia Z., Ge J. Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats. Cell Transplant 2005, 14:787-798.
37. Lee J.W., Lee S.H., Youn Y.J., Ahn M.S., Kim J.Y., Yoo B.S., et al. A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction. J Korean Med Sci 2013, 29:23-31.
38. Heldman A.W., Difede D.L., Fishman J.E., Zambrano J.P., Trachtenberg B.H., Karantalis V., et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 2013, [Epub ahead of print]. 10.1001/jama.2013.282909.
39. Hare J.M., Traverse J.H., Henry T.D., Dib N., Strumpf R.K., Schulman S.P., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009, 54:2277-2286.
40. Hare J.M., Fishman J.E., Gerstenblith G., DiFede Velazquez D.L., Zambrano J.P., Suncion V.Y., et al. Comparison of allogeneic vs autologous bone marrow - derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012, 308:2369-2379.
41. Lee J.W., Lee S.H., Youn Y.J., Ahn M.S., Kim J.Y., Yoo B.S., et al. A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction. J Korean Med Sci 2014, 29:23-31.
42. Hosoda T., Rota M., Kajstura J., Leri A., Anversa P. Role of stem cells in cardiovascular biology. J Thromb Haemost 2011, 9(Suppl. 1):151-161.
43. Williams A.R., Hare J.M. Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 2011, 109:923-994.
44. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
45. Huang N.F., Li S. Mesenchymal stem cells for vascular regeneration. Regen Med 2008, 3:877-892.
46. Okura H., Matsuyama A., Lee C.M., Saga A., Kakuta-Yamamoto A., Nagao A., et al. Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model. Tissue Eng. C Methods 2010, 16:417-425.
47. Houtgraaf J.H., den Dekker W.K., van Dalen B.M., Springeling T., de Jong R., van Geuns R.J., et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2012, 59:539-540.
48. Perin E.C., Sanchez P.L., Ruiz R.S., Perez-Cano R., Lasso J., Alonso-Farto J.C., et al. First in man transendocardial injection of autologous adipose-derived stem cells in patients with non revascularizable ischemic myocardium (PRECISE). Circulation 2010, 122:A17966. Abstract.
49. Hida N., Nishiyama N., Miyoshi S., Kira S., Segawa K., Uyama T., et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 2008, 26:1695-1704.
50. Bockeria L., Bogin V., Bockeria O., Le T., Alekyan B., Woods E.J., et al. Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic. J Transl Med 2013, 11:56.
51. Bearzi C., Rota M., Hosoda T., Tillmanns J., Nascimbene A., De Angelis A., et al. Human cardiac stem cells (2007). Proc Natl Acad Sci U S A 2007, 104:14068-14073.
52. Hosoda T. C-kit-positive cardiac stem cells and myocardial regeneration. Am J Cardiovasc Dis 2012, 2:58-67.
53. Lee S.T., White A.J., Matsushita S., Malliaras K., Steenbergen C., Zhang Y., et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol 2011, 57:455-465.
54. Johnston P.V., Sasano T., Mills K., Evers R., Lee S.T., Smith R.R., et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009, 120:1075-1083.
55. Bolli R., Chugh A.R., D'Amario D., Loughran J.H., Stoddard M.F., Ikram S., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011, 378:1847-1857.
56. Makkar R.R., Smith R.R., Cheng K., Malliaras K., Thomson L.E., Berman D., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012, 379:895-904.
57. Smith R.R., Marbán E., Marbán L. Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel. Biomatter 2013, 3:e24490.
58. Gersh B.J., Simari R.D., Behfar A., Terzic C.M., Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc 2009, 84:876-892.
59. Hare J.M., Chaparro S.V. Cardiac regeneration and stem cell therapy. Curr Opin Org Transplant 2008, 13:536-542.
60. van der Bogt K.E., Sheikh A.Y., Schrepfer S., Hoyt G., Cao F., Ransohoff K.J., et al. Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 2008, 118:121-129.
61. Christoforou N., Gearhart J.D. Stem cells and their potential in cell-based cardiac therapies. Prog Cardiovasc Dis 2007, 49:396-413.
62. Brunskill S.J., Hyde C.J., Doree C.J., Watt S.M., Martin-Rendon E. Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. Eur J Heart Fail 2009, 11:887-896.
63. Assmus B., Rolf A., Erbs S., Elsässer A., Haberbosch W., Hambrecht R., et al. Schächinger V; REPAIR-AMI Investigators. Clinical outcome 2years after intracoronary administration of bone marrow-derived progenitorcells in acute myocardial infarction. Circ Heart Fail 2010, 3:89-96.
64. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
65. Ge J., Li Y., Qian J., Shi J., Wang Q., Niu Y., et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 2006, 92:1764-1767.
66. Lunde K., Solheim S., Forfang K., Arnesen H., Brinch L., Bjørnerheim R., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006, 355:1199-1209.
67. Huikuri H.V., Kervinen K., Niemelä M., Ylitalo K., Säily M., Koistinen P., et al. FINCELL Investigators. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 2008, 29:2723-2732.
68. Diederichsen A.C., Møller J.E., Thayssen P., Junker A.B., Videbaek L., Saekmose S.G., et al. Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure the Danish stem cell study-congestive heart failure trial (DanCell-CHF). Scand Cardiovasc J 2010, 44:139-145.
69. Roncalli J., Mouquet F., Piot C., Trochu J.N., Le Corvoisier P., Neuder Y., et al. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J 2011, 32:1748-1757.
70. Assmus B., Walter D.H., Seeger F.H., Leistner D.M., Steiner J., Ziegler I., et al. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. JAMA 2013, 309:1622-1631.
71. Hirsch A., Nijveldt R., van der Vleuten P.A., Tijssen J.G., van der Giessen W.J., Tio R.A., et al. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J 2011, 32:1736-1747. HEBE Investigators.
72. Traverse J.H., Henry T.D., Ellis S.G., Pepine C.J., Willerson J.T., Zhao D.X., et al. Cardiovascular Cell Therapy Research Network. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3weeks following acute myocardial infarction on left ventricular function: the Late TIME randomized trial. JAMA 2011, 306:2110-2119.
73. Gyöngyösi M., Lang I., Dettke M., Beran G., Graf S., Sochor H., et al. Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med 2009, 6:70-81.
74. Tse H.F., Thambar S., Kwong Y.L., Rowlings P., Bellamy G., McCrohon J., et al. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J 2007, 28:2998-3005.
75. Losordo D.W., Schatz R.A., White C.J., Udelson J.E., Veereshwarayya V., Durgin M., et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007, 115:3165-3172.
76. Mansour S., Roy D.C., Bouchard V., Stevens L.M., Gobeil F., Rivard A., et al. One-year safety analysis of the COMPARE-AMI Trial: Comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction. Bone Marrow Res 2011, 385124.
77. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004, 94:92-95.
78. Mathiasen A.B., Jørgensen E., Qayyum A.A., Haack-Sørensen M., Ekblond A., Kastrup J. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial). Am Heart J 2012, 164:285-291.
79. Fuchs S., Kornowski R., Weisz G., Satler L.F., Smits P.C., Okubagzi P., et al. Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol 2006, 97:823-829.
80. Choi J.H., Choi J., Lee W.S., Rhee I., Lee S.C., Gwon H.C., et al. Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarction. Circ J 2007, 71:486-494.
81. Dib N., Dinsmore J., Lababidi Z., White B., Moravec S., Campbell A., et al. One-year follow-up of feasibility and safety of the first US, randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc Interv 2009, 2:9-16.
82. Bartunek J., Behfar A., Dolatabadi D., Vanderheyden M., Ostojic M., Dens J., et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol 2013, 61:2329-2338.
83. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
84. Kajstura J., Rota M., Whang B., Cascapera S., Hosoda T., Bearzi C., et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005, 96:127-137.
85. Planat-Bénard V., Menard C., André M., Puceat M., Perez A., Garcia-Verdugo J.M., et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004, 94:223-229.
86. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemicmyocardium. Nature 2004, 428:668-673.
87. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
88. Gruh I., Beilner J., Blomer U., Schmiedl A., Schmidt-Richter I., Kruse M.L., et al. No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 2006, 113:1326-1334.
89. Nygren J.M., Jovinge S., Breitbach M., Säwén P., Röll W., Hescheler J., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004, 10:494-501.
90. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002, 416:542-545.
91. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., Fike J.R., Lee H.O., Pfeffer K., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003, 425:968-973.
92. Wagers A.J., Sherwood R.I., Christensen J.L., Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002, 297:2256-2259.
93. Noiseux N., Gnecchi M., Lopez-Ilasaca M., Zhang L., Solomon S.D., Deb A., et al. Mesenchymal stem cells overexpressing akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006, 14:840.
94. Steinhauser M.L., Lee R.T. Regeneration of the heart. EMBO Mol Med 2011, 3:701-712.
95. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:367-368.
96. Lichtenauer M., Mildner M., Baumgartner A., Hasun M., Werba G., Beer L., et al. Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol 2011, 106:645-655.
97. Steinhauser M.L., Lee R.T. Cardiovascular regeneration: pushing and pulling on progenitors. Cell Stem Cell 2009, 4:277-278.
98. Loffredo F.S., Steinhauser M.L., Gannon J., Lee R.T. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011, 8:389-398.
99. Penicka M., Widimsky P., Kobylka P., Kozak T., Lang O. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. Circulation 2005, 112:e63-e65.
100. Aicher A., Brenner W., Zuhayra M., Badorff C., Massoudi S., Assmus B., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003, 107:2134-2139.
101. Gyöngyösi M., Hemetsberger R., Wolbank S., Kaun C., Posa A., Marian T., et al. Imaging the migration of therapeutically delivered cardiac stem cells. JACC Cardiovasc Imaging 2010, 3:772-775.
102. Dib N., Menasche P., Bartunek J.J., Zeiher A.M., Terzic A., Chronos N.A., et al. International Society for Cardiovascular Translational Research. International Society for Cardiovascular Translational Research. Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc Interv 2010, 3:265-275.
103. Charwat S., Gyöngyösi M., Lang I., Graf S., Beran G., Hemetsberger R., et al. Role of adult bone marrow stem cells in the repair of ischemic myocardium: Current state of the art. Exp Hematol 2008, 36:672-680.
104. Gyöngyösi M., Dib N. Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease. Nat Rev Cardiol 2011, 8:393-404.
105. Bui Q.T., Gertz Z.M., Wilensky R.L. Intracoronary delivery of bone-marrow-derived stem cells. Stem Cell Res Ther 2010, 1:29.
106. Malliaras K., Marban E. Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull 2011, 98:161-185.
107. Menasché P., Hagège A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., et al. Myoblast transplantation for heart failure. Lancet 2001, 357:279-280.
108. Hamano K., Nishida M., Hirata K., Mikamo A., Li T.S., Harada M., et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 2001, 65:845-847.
109. Heeger C.H., Jaquet K., Thiele H., Zulkarnaen Y., Cuneo A., Haller D., et al. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial. EuroIntervention. Eurointervention 2012, 8:732-742.
110. Schächinger V., Erbs S., Elsässer A., Haberbosch W., Hambrecht R., Hölschermann H., et al. REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355:1210-1221.
111. Martin-Rendon E., Brunskill S.J., Hyde C.J., Stanworth S.J., Mathur A., Watt S.M. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008, 29:1807-1818.
112. Abdel-Latif A., Bolli R., Tleyjeh I.M., Montori V.M., Perin E.C., Hornung C.A., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007, 167:989-997.
113. Traverse J.H., Henry T.D., Pepine C.J., Willerson J.T., Zhao D.X., Ellis S.G., et al. Cardiovascular Cell Therapy Research Network (CCTRN) (2012). Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial 2012, 308:2380-2389.
114. Sürder D., Manka R., Lo Cicero V., Moccetti T., Rufibach K., Soncin S., et al. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation 2013, 127:1968-1979.
115. Fernández-Avilés F., San Román J.A., García-Frade J., Fernández M.E., Peñarrubia M.J., de la Fuente L., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004, 95:742-748.
116. Strauer B.E., Brehm M., Zeus T., Bartsch T., Schannwell C., Antke C., et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 2005, 46:1651-1658.
117. Katritsis D.G., Sotiropoulou P.A., Karvouni E., Karabinos I., Korovesis S., Perez S.A., et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Cath Cardiovasc Interv 2005, 65:321-329.
118. Ruan W., Pan C.Z., Huang G.Q., Li Y.L., Ge J.B., Shu X.H. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging. Chin Med J (Engl) 2005, 118:1175-1181.
119. Erbs S., Linke A., Adams V., Lenk K., Thiele H., Diederich K.W., et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 2005, 97:756-762.
120. Assmus B., Fischer-Rasokat U., Honold J., Seeger F.H., Fichtlscherer S., Tonn T., et al. TOPCARE-CHD Registry. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res 2007, 100:1234-1241.
121. Meluzín J., Mayer J., Groch L., Janousek S., Hornácek I., Hlinomaz O., et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 2006, 152(975):e9-e15.
122. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., et al. Autologous bone-marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006, 367:113-121.
123. Penicka M., Horak J., Kobylka P., Pytlik R., Kozak T., Belohlavek O., et al. Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: A prematurely terminated randomized study. J Am Coll Cardiol 2007, 49:2373-2374.
124. Suárez de Lezo J., Herrera C., Pan M., Romero M., Pavlovic D., Segura J., et al. Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function. Rev Esp Cardiol 2007, 60:357-365.
125. Tatsumi T., Ashihara E., Yasui T., Matsunaga S., Kido A., Sasada Y., et al. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J 2007, 71:1199-1207.
126. Plewka M., Krzeminska-Pakula M., Lipiec P., Peruga J.Z., Jezewski T., Kidawa M., et al. Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction. Am J Cardiol 2009, 104:1336-1342.
127. Obradovic S., Balint B., Romanovic R., Trifunovic Z., Rusovic S., Baskot B., et al. Influence of intracoronary injections of bone-marrow-derived mononuclear cells on large myocardial infarction outcome: quantum of initial necrosis is the key. Vojnosanit Pregl 2009, 66:998-1004.
128. Fischer-Rasokat U., Assmus B., Seeger F.H., Honold J., Leistner D., Fichtlscherer S., et al. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2009, 2:417-423.
129. Wöhrle J., Merkle N., Mailänder V., Nusser T., Schauwecker P., von Scheidt F., et al. Results of intracoronary stem cell therapy after acute myocardial infarction. Am J Cardiol 2010, 105:804-812.
130. Piepoli M.F., Vallisa D., Arbasi M., Cavanna L., Cerri L., Mori M., et al. Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). Eur J Heart Fail 2010, 12:172-180.
131. Grajek S., Popiel M., Gil L., Breborowicz P., Lesiak M., Czepczynski R., et al. Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. Eur Heart J 2010, 31:691-702.
132. Revilla A., López J., Arnold R., Sánchez P.L., Villa A., Pinedo M., et al. Long-term changes in left ventricular function following intracoronary stem cell transplantation for acute myocardial infarction. Rev Esp Cardiol 2011, 64:334-337.
133. Santoso T., Irawan C., Alwi I., Aziz A., Kosasih A., Inggriani S., et al. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: One-year follow-up of A Phase 1 Study. Acta Med Indones 2011, 43:112-121.
134. Turan R.G., Bozdag-Turan I., Ortak J., Akin I., Kische S., Schneider H., et al. Improvement of cardiac function by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction. Circ J 2011, 75:683-691.
135. Traverse J.H., Henry T.D., Moye L.A. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging. Am Heart J 2011, 162:671-677.
136. Vrtovec B., Poglajen G., Sever M., Lezaic L., Domanovic D., Cernelc P., et al. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J Card Fail 2011, 17:272-281.
137. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Mesquita C.T., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003, 107:2294-2302.
138. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Silva G.V., et al. Improved exercise capacity and ischemia 6 and 12months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004, 110(11Suppl. 1):II213-II218.
139. Briguori C., Reimers B., Sarais C., Napodano M., Pascotto P., Azzarello G., et al. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J 2006, 151:674-680.
140. Beeres S.L., Bax J.J., Dibbets-Schneider P., Stokkel M.P., Fibbe W.E., van der Wall E.E., et al. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol 2007, 100:1094-1098.
141. Beeres S.L., Zeppenfeld K., Bax J.J., Dibbets-Schneider P., Stokkel M.P., Fibbe W.E., et al. Electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease. Heart Rhythm 2007, 4:257-265.
142. Beeres S.L., Bax J.J., Roes S.D., Lamb H.J., Fibbe W.E., De Roos A., et al. Intramyocardial bone marrow cell transplantation and the progression of coronary atherosclerosis in patients with chronic myocardial ischemia. Acute Card Care 2007, 9:243-251.
143. van Ramshorst J., Bax J.J., Beeres S.L., Dibbets-Schneider P., Roes S.D., Stokkel M.P., et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 2009, 301:1997-2004.
144. Krause K., Jaquet K., Schneider C., Haupt S., Lioznov M.V., Otte K.M., et al. Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study. Heart 2009, 95:1145-1152.
145. Jiménez-Quevedo P., Silva G.V., Sanz-Ruiz R., Oliveira E.M., Fernandes M.R., Angeli F., et al. Diabetic and nondiabetic patients respond differently to transendocardial injection of bone marrow mononuclear cells: findings from prospective clinical trials in no-option patients [Spanish]. Rev Esp Cardiol 2008, 61:635-639.
146. Pokushalov E., Romanov A., Chernyavsky A., Larionov P., Terekhov I., Artyomenko S., et al. Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study. J Cardiovasc Transl Res 2013, 3:160-168.
147. Perin E.C., Willerson J.T., Pepine C.J., Henry T.D., Ellis S.G., Zhao D.X., et al. Cardiovascular Cell Therapy Research Network (CCTRN). Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 2012, 307(16):1717-1726.
148. Colombo A., Castellani M., Piccaluga E., Pusineri E., Palatresi S., Longari V., et al. Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial. J Cardiovasc Med (Hagerstown) 2011, 12:239-248.
149. Lasala G.P., Silva J.A., Kusnick B.A., Minguell J.J. Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study. Cardiovasc Revasc Med 2011, 12:29-34.
150. Castellani M., Colombo A., Giordano R., Pusineri E., Canzi C., Longari V., et al. The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection. J Nucl Med 2010, 51:1908-1916.
151. Nogueira F.B., Silva S.A., Haddad A.F., Peixoto C.M., Carvalho R.M., Tuche F.A., et al. Systolic function of patients with myocardial infarction undergoing autologous bone marrow transplantation. Arq Bras Cardiol 2009, 93:367-379.
152. Kovacic J.C., Macdonald P., Feneley M.P., Muller D.W., Freund J., Dodds A., et al. Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial. Am Heart J 2008, 156:954-963.
153. Bocchi E.A., Bacal F., Guimarães G., Mendroni A., Mocelin A., Filho A.E., et al. Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure. Int J Cardiol 2010, 138:94-97.
154. Yelda T., Berrin U., Murat S., Aytac O., Sevgi B., Yasemin S., et al. Intracoronary stem cell infusion in heart transplant candidates. Tohoku J Exp Med 2007, 213:113-120.
155. Balogh L., Czuriga I., Hunyadi J., Galuska L., Kristóf E., Edes I. Effects of autologous bone marrow derived CD34+ stem cells on the left ventricular function following myocardial infarction. Orv Hetil 2007, 148:243-249.
156. Gao L.R., Wang Z.G., Zhu Z.M., Fei Y.X., He S., Tian H.T., et al. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy. Am J Cardiol 2006, 98:597-602.
157. Houtgraaf J.H., den Dekker W.K., van Dalen B.M., Springeling T., de Jong R., van Geuns R.J., et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2012, 59:539-540.
158. Wang S., Cui J., Peng W., Lu M. Intracoronary autologous CD34+ stem cell therapy for intractable angina. Cardiology 2010, 117:140-147.
159. Zohlnhöfer D., Dibra A., Koppara T., de Waha A., Ripa R.S., Kastrup J., et al. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J Am Coll Cardiol 2008, 51:1429-1437.
160. Ripa R.S., Jørgensen E., Wang Y., Thune J.J., Nilsson J.C., Søndergaard L., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction. Result of the double-blind, randomized, placebo-controlled stem cells in myocardialis infarction (STEMMI) trial. Circulation 2006, 113:1983-1992.
161. Zohlnhöfer D., Ott I., Mehilli J., Schömig K., Michalk F., Ibrahim T., et al. Stem cell mobilization by granulocyte colony stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 2006, 295:1003-1010.
162. Engelmann M.G., Theiss H.D., Hennig-Theiss C., Huber A., Wintersperger B.J., Werle-Ruedinger A.E., et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 2006, 48:1712-1721.
163. Leone A.M., Galiuto L., Garramone B., Rutella S., Giannico M.B., Brugaletta S., et al. Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA study). Am J Cardiol 2007, 100:397-403.
164. Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner C., Klinge H., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003, 361:45-46.
165. Menasché P., Hagège A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003, 41:1078-1083.
166. Siminiak T., Kalawski R., Fiszer D., Jerzykowska O., Rzeniczak J., Rozwadowska N., et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12months of follow-up. Am Heart J 2004, 148:531-537.
167. Dib N., McCarthy P., Campbell A., Yeager M., Pagani F.D., Wright S., et al. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant 2005, 14:11-19.
168. Francis D.P., Mielewczik M., Zargaran D., Cole G.D. Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions. Int J Cardiol 2013 Oct 9, 168(4):3381-3403.
169. Jeevanantham V., Butler M., Saad A., Abdel-Latif A. Zuba-Surma Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. EK, Dawn B. Circulation 2012, 126:551-568.
170. Nowbar A.N., Mielewczik M., Karavassilis M., Dehbi H.M., Shun-Shin M.J., Jones S., et al. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ. 2014, 348:g2688.
171. Lipinski M.J., Biondi-Zoccai G.G., Abbate A., Khianey R., Sheiban I., Bartunek J., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007, 50:1761-1767.
172. Wen J., Meng L., Ding Y., Ouyang J. Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease. Int J Clin Pract 2011, 65:858-865.
173. Reffelmann T., Kloner R.A. Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease. Regen Med 2009, 4:709-719.
174. Zhang S., Sun A., Xu D., Yao K., Huang Z., Jin H., et al. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials. Int J Cardiol 2009, 136:178-185.
175. Zhang S., Sun A., Xu D., et al. (2009). Impact of timing on efficacy and safety of intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials. Clin Cardiol 2009, 32:458-466.
176. Brunskill S.J., Hyde C.J., Doree C.J., Watt S.M., Martin-Rendon E. Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. Eur J Heart Fail 2009, 11:887-896.
177. Singh S., Arora R., Handa K., Khraisat A., Nagajothi N., Molnar J., et al. Stem cells improve left ventricular function in acute myocardial infarction. Clin Cardiol 2009, 32:176-180.
178. Kang S., Yang Y.J., Li C.J., Gao R.L. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis 2008, 19:327-335.
179. Zimmet H., Porapakkham P., Porapakkham P., Sata Y., Haas S.J., Itescu S., et al. Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. Eur J Heart Fail 2012, 14:91-105.
180. Fisher S.A., Dorée C., Brunskill S.J., Mathur A., Martin-Rendon E. Bone marrow stem cell treatment for ischemic heart disease in patients with no option of revascularization: A systematic review and meta-analysis. PLoS One 2013, 19(8):e64669.
181. Li N., Yang Y.J., Zhang Q., Jin C., Wang H., Qian H.Y. Stem cell therapy is a promising tool for refractory angina: A meta-analysis of randomized controlled trials. Can J Cardiol 2013, 29:908-914.
182. Tura B.R., Martino H.F., Gowdak L.H., dos Santos R.R., Dohmann H.F., Krieger J.E., et al. Multicenter randomized trial of cell therapy in cardiopathies - MiHeart Study. Trials 2007, 8:2.
183. Gyöngyösi M., Khorsand A., Zamini S., Sperker W., Strehblow C., Kastrup J., et al. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study. Circulation 2005, 112(Suppl. I):I-157-I-165.
184. Gyöngyösi M., Blanco J., Marian T., Trón L., Petneházy O., Petrasi Z., et al. Serial non-invasive in vivo positron emission tomographic (PET) tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging 2008, 1:94-103.
185. Simari R.D., Moyé L.A., Skarlatos S.I., Ellis S.G., Zhao D.X., Willerson J.T., et al. Development of a network to test strategies in cardiovascular cell delivery. The NHLBI sponsored cardiovascular cell therapy research network (CCTRN). J Cardiovasc Transl Res 2009, 3:30-36.
186. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOnemarrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006, 113:1287-1294.
187. Beitnes J.O., Hopp E., Lunde K., Solheim S., Arnesen H., Brinchmann J.E., et al. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart 2009, 95:1983-1989.
188. Yousef M., Schannwell C.M., Köstering M., Zeus T., Brehm M., Strauer B.E. The BALANCE study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardialinfarction. J Am Coll Cardiol 2009, 53:2262-2269.
189. Cao F., Sun D., Li C., Narsinh K., Zhao L., Li X., et al. Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4years follow-up. Eur Heart J 2009, 30:1986-1994.
190. Leistner D.M., Fischer-Rasokat U., Honold J., Seeger F.H., Schächinger V., Lehmann R., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clin Res Cardiol 2010, 100:925-934.
191. Gyöngyösi M., Syeda B., Bergler-Klein J., Gieseking E., Glogar D., Lang I.M., et al. Long-term improvement of left ventricular function and infarct size after cardiac stem cell therapy: 5-years follow-up of the MYSTAR study. Circulation 2012, 126. A17537.
192. Boheler K.R., Czyz J., Tweedie D., Yang H.T., Anisimov S.V., Wobus A.M. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 2002, 91:189-201.
193. He J.Q., Ma Y., Lee Y., Thomson J.A., Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization. Circ Res 2003, 93:32-39.
194. Menasché P. The potential of embryonic stem cells to treat heart disease. Curr Opin Mol Ther 2005, 7:293-299.
195. Hodgson D.M., Behfar A., Zingman L.V., Kane G.C., Perez-Terzic C., Alekseev A.E., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 2004, 287:H471-H479.
196. Yamanaka S., Blau H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010, 465:704-712.
197. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
198. Meissner A., Wernig M., Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007, 25:1177-1181.
199. Boulting G.L., Kiskinis E., Croft G.F., Amoroso M.W., Oakley D.H., Wainger B.J., et al. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotech 2011, 29:279-286.
200. Miura K., Okada Y., Aoi T., Okada A., Takahashi K., Okita K., et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotech 2009, 27:743-745.
201. Liu Z., Wen X., Wang H., Zhou J., Zhao M., Lin Q., et al. Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium. PLoS One 2013, 8(6):e66369.
202. Nam Y.J., Song K., Luo X., Daniel E., Lambeth K., West K., et al. Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci U S A 2013, 110:5588-5593.
203. Miki K., Yoshida Y., Yamanaka S. Making steady progress on direct cardiac reprogramming toward clinical application. Circ Res 2013, 113:13-15.
204. Martinez-Fernandez A., Nelson T.J., Terzic A. Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells. J Cardiovasc Trans Res 2011, 4:131-137.
205. Wollert K.C., Drexler H. Cell therapy for the treatment of coronary heart disease: A critical appraisal. Nat Rev Cardiol 2010, 7:204-215.
206. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473:326-335.
207. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., et al. Human mesenchymal stem cells alter antigenpresenting cell maturation and induce T-cell unresponsiveness. Blood 2005, 105:2214-2219.
208. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
209. Schulman I.H., Hare J.M. Key developments in stem cell therapy in cardiology. Regen Med 2012, 7:17-24.
210. Williams A.R., Hatzistergos K.E., Addicott B., McCall F., Carvalho D., Suncion V., et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 2013 Jan 15, 127(2):213-223.
211. Chugh A.R., Beache G.M., Loughran J.H., Mewton N., Elmore J.B., Kajstura J., et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 2012, 126:S54-S64.
212. Behfar A., Terzic A. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nat Clin Pract Cardiovasc Med 2006, 3(Suppl. 1):S78-S82.
213. Gupta M.K., Walthall J.M., Venkataraman R., Crowder S.W., Jung D.K., Yu S.S., et al. Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation. PLoS One 2011, 6:e28935.
214. Venugopal J.R., Prabhakaran M.P., Mukherjee S., Ravichandran R., Dan K., Ramakrishna S. Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface 2012, 9:1-19.
215. Seif-Naraghi S.B., Salvatore M.A., Schup-Magoffin P.J., Hu D.P., Christman K.L. Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng A 2010, 16:2017-2027.
216. Vunjak-Novakovic G., Lui K.O., Tandon N., Chien K.R. Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng 2011, 13:245-267.
217. Gojo S., Kyo S. Cardiac regenerative medicine - cellular therapy and tissue engineering. Circ J 2009, 73. Suppl. A:A61-A71.
218. Jawad H., Lyon A.R., Harding S.E., Ali N.N., Boccaccini A.R. Myocardial tissue engineering. Br Med Bull 2008, 87:31-47.
219. Segers V.F., Van Riet I., Andries L.J., Lemmens K., Demolder M.J., De Becker A.J., et al. Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol 2006, 290:H1370-H1377.
220. Di Santo S., Yang Z., Wyler von Ballmoos M., Voelzmann J., Diehm N., Baumgartner I., et al. Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 2009, 4:e5643.
221. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204-1219.
222. Korf-Klingebiel M., Kempf T., Sauer T., Brinkmann E., Fischer P., Meyer G.P., et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 2008, 29:2851-2858.
223. Thum T., Bauersachs J., Poole-Wilson P.A., Volk H.D., Anker S.D. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 2005, 46:1799-1802.
224. Ankersmit H.J., Hoetzenecker K., Dietl W., Soleiman A., Horvat R., Wolfsberger M., et al. Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Investig 2009, 39:445-456.
225. Lichtenauer M., Mildner M., Baumgartner A., Hasun M., Werba G., Beer L., et al. Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol 2011, 106:645-655.
226. Lichtenauer M., Mildner M., Hoetzenecker K., Zimmermann M., Podesser B.K., Sipos W., et al. Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Res Cardiol 2011, 106:1283-1297.
227. Gupta S.K., Bang C., Thum T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet 2010, 3:484-488.
228. Pavo N., Zimmermann M., Pils D., Mildner M., Petrási Z., Petneházy Ö., et al. Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction. Biomaterials 2014, 35:3541-3550.
229. Arslan F., Lai R.C., Smeets M.B., Akeroyd L., Choo A., Aguor E.N., et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 2013, 10:301-312.
230. Kastrup J., Jørgensen E., Rück A., Tägil K., Glogar D., Ruzyllo W., et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol 2005, 45:982-988.
231. Penn M.S., Mendelsohn F.O., Schaer G.L., Sherman W., Farr M., Pastore J., et al. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res 2013, 112:816-825.
232. Hinkel R., Penzkofer D., Zuhlke S., Fischer A., Husada W., Xu Q.F., et al. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation 2013, 128:1066-1075.